Biohaven (BHVN) Capital Expenditures (2021 - 2026)
Biohaven's Capital Expenditures came in at $180,000 for Q3 2026, compared with $13,000 a year earlier and down 60.4% from the prior quarter.
Biohaven (BHVN) Capital Expenditures (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Biohaven reported Capital Expenditures of $642,000, down 15.1% year-over-year; for FY2025, it was $715,000, down 82.3% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -23.3% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $4.05 million in FY2024 (+32.8%), $3.05 million in FY2023 (-49.8%), $6.07 million in FY2022 (+547.5%) and $938,000 in FY2021 (-65.2%).
- The five-year range for quarterly Capital Expenditures is $8,000 (Q4 2025) to $4.52 million (Q3 2022).
- Year-over-year, Capital Expenditures increased in two of the last six quarters, with an average decline of 43.9%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q2 2024 (growth of 395.6%), and the weakest in Q3 2025 (a decline of 97.9%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Biohaven | 2.28 Bn | 1.18 Bn | - | 180,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 180,000.00 |
| Jun 30, 2026 | 454,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 233,000.00 |
| Mar 31, 2025 | 461,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 611,000.00 |
| Jun 30, 2024 | 2.95 Mn |
| Mar 31, 2024 | 440,000.00 |
| Dec 31, 2023 | 470,000.00 |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 595,000.00 |
| Mar 31, 2023 | 735,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 4.52 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 246,000.00 |
| Dec 31, 2021 | 201,000.00 |
Biohaven Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BHVN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BHVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BHVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();